Despite the last two decades having been groundbreaking in treatment of AMD due to the introduction of anti-VEGF injections and photodynamic therapy, to date, there are no effective treatments to prevent progressive irreversible degeneration of light-sensitive cells in the macula, especially in the atrophic form of the disease and the need for a new approach is crucial [3]. This evidence concerns the gene VEGFA and age-related macular degeneration.